Hikma continued strategic progress and updated full-year guidance following Custopharm acquisition 3 min read People and Community Hikma continued strategic progress and updated full-year guidance following Custopharm acquisition AETOSWire April 29, 2022 London, England – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on...Read More
